Weiss, T., Schneider, H., Silginer, M., Steinle, A., Pruschy, M., Polić, B. ... Roth, P. (2018). NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma. Clinical Cancer Research, 24. (4), 882-895. doi: 10.1158/1078-0432.CCR-17-1766
Weiss, Tobias, et al. "NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma." Clinical Cancer Research, vol. 24, no. 4, 2018, pp. 882-895. https://doi.org/10.1158/1078-0432.CCR-17-1766
Weiss, Tobias, Hannah Schneider, Manuela Silginer, Alexander Steinle, Martin Pruschy, Bojan Polić, Michael Weller and Patrick Roth. "NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma." Clinical Cancer Research 24, no. 4 (2018): 882-895. https://doi.org/10.1158/1078-0432.CCR-17-1766
Weiss, T., et al. (2018) 'NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma', Clinical Cancer Research, 24(4), pp. 882-895. doi: 10.1158/1078-0432.CCR-17-1766
Weiss T, Schneider H, Silginer M, Steinle A, Pruschy M, Polić B, and sur.. NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma. Clinical Cancer Research [Internet]. 2018 February 15 [cited 2024 December 25];24(4):882-895. doi: 10.1158/1078-0432.CCR-17-1766
T. Weiss, et al., "NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma", Clinical Cancer Research, vol. 24, no. 4, pp. 882-895, February 2018. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:482828. [Accessed: 25 December 2024]